Abbott Ireland Diagnostics Division · Class II · Cleared Mar 22, 2022
| K-number | K210452 |
| Device name | Creatinine2 |
| Applicant | Abbott Ireland Diagnostics Division |
| Product code | CGX |
| Device class | Class II |
| Decision date | Mar 22, 2022 |
| Decision | Substantially Equivalent |
| Regulation | 862.1225 |
AI extraction for this record is queued and will appear within 24 hours. View full FDA record →
View the full FDA submission: accessdata.fda.gov